Literature DB >> 9326186

Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism.

S Morichika1, M Shima, S Kamisue, I Tanaka, Y Imanaka, H Suzuki, H Shibata, S Pemberton, K Gale, J McVey, E G Tuddenham, A Yoshioka.   

Abstract

Haemophilia A is the most common X-linked blood coagulation disorder; it is caused by deficiency of factor VIII activity (FVIII:C). Half of the affected patients do not have detectable levels of FVIII protein in their plasma, whereas about 5% have normal levels of the FVIII antigen (FVIII:Ag) (> 50 u/dl), and are called cross-reacting material (CRM) positive (CRM+ or A+). About 45% of patients have reduced levels of the FVIII:Ag (1-50 u/dl), classified as CRM reduced (CRM[R] or A[R]). We screened the FVIII gene of 13 Japanese patients (five CRM+ and eight CRM[R]) by single-strand conformation polymorphism, and identified 11 different mutations in 13 patients by analysing all 26 exons (Trp255Cys, Tyr473Cys, Gly479Arg, Arg531His, Thr667Arg, Arg1689Cys, Arg1941Gln, Arg2150His, Arg2159Cys, Thr2245Ala and Gly2285Val). Seven mutations were identified in the A domains (four in the A2 domain). All the mutations are point mutations resulting in missense codons. Four mutations (Trp255Cys, Thr667Arg, Thr2245Ala and Gly2285Val) have not been described previously.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326186     DOI: 10.1046/j.1365-2141.1997.2963113.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A.

Authors:  Hiroshi Inaba; Keiko Shinozawa; Ikuo Seita; Manabu Otaki; Takashi Suzuki; Takeshi Hagiwara; Kagehiro Amano; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2013-04-27       Impact factor: 2.490

2.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.